The Intellectual Property & Science business of Thomson Reuters and the University of Melbourne have announced an initiative to increase the impact of the institution's research in the life sciences with the implementation of Cortellis Competitive Intelligence, the life sciences industry's premier source of timely and accurate information on drug pipeline data, patents, companies and the latest industry news, providing a comprehensive view of the competitive landscape in a selected therapy area.
This initiative will ensure that University of Melbourne's students have access to the highest quality life science content, including disease briefing and SWOT analysis to better inform their research and provide them with the ability to gain a competitive advantage toward pursuing their future professions with a fluency in Cortellis.
Times Higher Education World University Ranking recently named the University of Melbourne as 13th in the world in Clinical, Pre-Clinical and Health disciplines.
